These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 14565176)
1. HIV pathogenesis and treatment--second International AIDS Society conference. 13-16 July 2003, Paris, France. Susman E IDrugs; 2003 Sep; 6(9):865-7. PubMed ID: 14565176 [No Abstract] [Full Text] [Related]
2. HIV Pathogenesis and Treatment - Third International AIDS Society Conference. Susman E IDrugs; 2005 Oct; 8(10):813-5. PubMed ID: 16254799 [No Abstract] [Full Text] [Related]
3. Setback prompts rethink of latency-reversing strategy to eliminate HIV infection. Katsnelson A Nat Rev Drug Discov; 2014 Jun; 13(6):403-4. PubMed ID: 24875082 [No Abstract] [Full Text] [Related]
4. Major HIV treatment conference in Paris--finding reports online. James JS AIDS Treat News; 2003 Jul; (393):5-8. PubMed ID: 14682268 [TBL] [Abstract][Full Text] [Related]
5. Drug Therapy in HIV Infection--Ninth International Congress. Kuritzkes DR IDrugs; 2009 Jan; 12(1):20-5. PubMed ID: 19127500 [No Abstract] [Full Text] [Related]
7. Antiretroviral therapy. What does the future hold? Johnson D Women Alive; 2005; ():1-2, 6. PubMed ID: 16329210 [No Abstract] [Full Text] [Related]
8. Virodene--support misguided. Spencer DC S Afr Med J; 1997 May; 87(5):613. PubMed ID: 9254822 [No Abstract] [Full Text] [Related]
9. [HIV therapy of the next generation. Modern active drugs for long-term treatment]. MMW Fortschr Med; 2012 May; 154 Suppl 1():50-1. PubMed ID: 22916603 [No Abstract] [Full Text] [Related]
10. Virodene--support misguided. Hugo BW S Afr Med J; 1997 May; 87(5):613. PubMed ID: 9254823 [No Abstract] [Full Text] [Related]
11. Investigational Antiretroviral Drugs: What is Coming Down the Pipeline. Gulick RM Top Antivir Med; 2018 Apr; 25(4):127-132. PubMed ID: 29689540 [TBL] [Abstract][Full Text] [Related]
12. AIDS 2010--XVIII International AIDS Conference. Desimmie BA IDrugs; 2010 Sep; 13(9):622-5. PubMed ID: 20799144 [TBL] [Abstract][Full Text] [Related]
13. Preclinical data released on PI. AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252 [No Abstract] [Full Text] [Related]
14. Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus. Stephenson J JAMA; 2007 Apr; 297(14):1535-6. PubMed ID: 17426263 [No Abstract] [Full Text] [Related]
15. International Society of Thrombosis and Hemostasis--XIXth Congress 12-18 July 2003, Birmingham, UK. Shah S IDrugs; 2003 Sep; 6(9):858-61. PubMed ID: 14565174 [No Abstract] [Full Text] [Related]
16. Potential new therapies for the treatment of HIV-1 infection. Condra JH; Miller MD; Hazuda DJ; Emini EA Annu Rev Med; 2002; 53():541-55. PubMed ID: 11818489 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Diseases Drug Discovery World Summit--SRI conference. 28-29 July 2003 San Diego, CA, USA. Knittel T IDrugs; 2003 Sep; 6(9):845-9. PubMed ID: 14565169 [No Abstract] [Full Text] [Related]
18. Phase 2 clinical trials started on PRO 140. AIDS Patient Care STDS; 2008 Feb; 22(2):159-60. PubMed ID: 18273941 [No Abstract] [Full Text] [Related]
19. The promise of CCR5 antagonists as new therapies for HIV-1. Repik A; Richards KH; Clapham PR Curr Opin Investig Drugs; 2007 Feb; 8(2):130-9. PubMed ID: 17328229 [TBL] [Abstract][Full Text] [Related]
20. [Impact of new antiretroviral therapy in HIV infected patients with virologic failure]. Costagliola D Med Sci (Paris); 2012; 28(8-9):706-7. PubMed ID: 22920871 [No Abstract] [Full Text] [Related] [Next] [New Search]